![](https://tracker.live.rns-distribution.com/track.live-rns/5264948_d9353a075fe0b610698e373da828b7e4.png)
Regulatory Announcement
RNS Number: 2940W
Bank of Montreal
July 12, 2024
The following prospectus has been approved by the Financial Conduct Authority and is available for viewing:
Prospectus dated July 12, 2024 relating to the U.S.$30,000,000,000 Note Issuance Programme of Bank of Montreal.
The Prospectus and the documents incorporated by reference therein have been submitted to the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus dated July 12, 2024 (the "Prospectus"), may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
The Notes have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or the securities laws of any state of the United States and are subject to United States tax law requirements. Subject to certain exceptions, the Notes may not be offered, sold or delivered, directly or indirectly, in the United States or to or for the account of a "U.S. person" (as defined in Regulation S under the Securities Act). No public offering of the Notes is being made in the United States. This announcement does not constitute an offer to sell or a solicitation to buy securities in the United States or in any other jurisdiction where such offer or solicitation would be unlawful.
Your right to access this service is conditional upon complying with the above requirement.
To view the full documents, please paste the following URLs into the address bar of your browser:
Prospectus dated July 12, 2024
http://www.rns-pdf.londonstockexchange.com/rns/2940W_1-2024-7-12.pdf
Documents Incorporated by Reference
2023 Annual Information Form
http://www.rns-pdf.londonstockexchange.com/rns/2940W_2-2024-7-12.pdf
2023 Annual Report
http://www.rns-pdf.londonstockexchange.com/rns/2940W_3-2024-7-12.pdf
Second Quarter 2024 Report to Shareholders
http://www.rns-pdf.londonstockexchange.com/rns/2940W_14-2024-7-12.pdf
2023 Management Discussion and Analysis
http://www.rns-pdf.londonstockexchange.com/rns/2940W_4-2024-7-12.pdf
Terms and Conditions from Prospectus dated July 14, 2023
http://www.rns-pdf.londonstockexchange.com/rns/2940W_9-2024-7-12.pdf
Terms and Conditions from Prospectus dated July 15, 2022
http://www.rns-pdf.londonstockexchange.com/rns/2940W_10-2024-7-12.pdf
Terms and Conditions from Prospectus dated July 16, 2021
http://www.rns-pdf.londonstockexchange.com/rns/2940W_12-2024-7-12.pdf
Terms and Conditions from Prospectus dated July 16, 2020
http://www.rns-pdf.londonstockexchange.com/rns/2940W_11-2024-7-12.pdf
Terms and Conditions from Prospectus dated July 11, 2019
http://www.rns-pdf.londonstockexchange.com/rns/2940W_8-2024-7-12.pdf
Terms and Conditions from Prospectus dated September 24, 2018
http://www.rns-pdf.londonstockexchange.com/rns/2940W_13-2024-7-12.pdf
Terms and Conditions from Prospectus dated January 19, 2018
http://www.rns-pdf.londonstockexchange.com/rns/2940W_5-2024-7-12.pdf
Terms and Conditions from Prospectus dated January 20, 2017
http://www.rns-pdf.londonstockexchange.com/rns/2940W_6-2024-7-12.pdf
Terms and Conditions from Prospectus dated January 22, 2016
http://www.rns-pdf.londonstockexchange.com/rns/2940W_7-2024-7-12.pdf
For further information, please contact:
Madeline Mann
Corporate Secretary's Dept.
Phone: (647) 268-6463
Email: madeline.mann@bmo.com
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.